0.90
+0.1245(+16.05%)
Currency In USD
Address
20271 Goldenrod Lane
Germantown, MD 20876
United States of America
Phone
480 659 6404
Website
Sector
Healthcare
Industry
Biotechnology
Employees
146
First IPO Date
March 13, 2012
| Name | Title | Pay | Year Born |
| Ms. Vered Caplan M.Sc. | Chairperson of the Board, Chief Executive Officer & President | 341,384 | 1969 |
| Prof. Sarah Ferber Ph.D. | Founder & Chief Scientific Officer | 268,319 | 1954 |
| Dr. Shimon Hassin Ph.D. | Chief Technology Officer | 0 | N/A |
| Mr. Victor Miller | Chief Financial Officer, Secretary & Treasurer | 0 | 1970 |
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland.